Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961687 · ClinicalTrials.gov registry record · NA
A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.
A NA study of Ventral Hernia and Incisional Hernia, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 16
- Study locations
NCT01961687: Completed NA study of Ventral Hernia and Incisional Hernia, sponsored by C. R. Bard.
NCT01961687 is a NA study of Ventral Hernia and Incisional Hernia that has completed, run by C. R. Bard. The registered enrollment target is 121 participants, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (11% lower). The trial reports 16 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01961687, a NA study of Ventral Hernia and Incisional Hernia, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 16
- Study locations
Study Summary
Single-arm study of Phasix Mesh in High Risk patients looking at SSI and recurrence rates.
Primary Outcome
Hernia recurrence rates will be assessed by physical examination at each study visit through 60 months. A recurrent hernia will be defined as any hernia identified or confirmed by the investigator, during any study follow-up visit, in approximately the same position as the hernia repaired in the study procedure. Potential hernias identified via incidental magnetic resonance imaging (MRI) or computed tomography (CT) scan will be evaluated by the operating surgeon for clinical significance and con
Conditions Studied
Interventions
- DEVICE Resorbable Mesh
Study Locations (16)
Tennessee
- Univerity of Tennessee Health Science Center - Germantown
- University of Tennessee Health Sciences Center - Knoxville
- Vanderbilt University Medical Center - Nashville
Massachusetts
- Baystate Medical Center - Springfield
- University of Massachusetts Worcester - Worcester
Wisconsin
- University of Wisconsin System - Madison
- Medical College of Wisconsin - Milwaukee
California
- University of California, San Diego - San Diego
Florida
- Florida Hospital/Celebration Health - Celebration
Illinois
- NorthShore University HealthSystem - Evanston
Indiana
- Indiana University - Indianapolis
Kentucky
- University of Kentucky Medical Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2013-09 |
| Est. Completion | 2020-01-27 |
| Phase | NA |
What the finished NCT01961687 record still lists
NCT01961687 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (11% lower).
The record links to 2 conditions, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Resorbable Mesh is the first listed.
NCT01961687 lists 16 locations in 12 states (Tennessee, Massachusetts, Wisconsin).
Frequently Asked Questions
What is clinical trial NCT01961687 about?
NCT01961687 is a clinical study titled "A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.". Single-arm study of Phasix Mesh in High Risk patients looking at SSI and recurrence rates.
What is the current status of trial NCT01961687?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2013-09. Estimated completion is 2020-01-27.
What conditions does trial NCT01961687 study?
This clinical trial studies the following conditions: Ventral Hernia, Incisional Hernia.
What interventions are being tested in trial NCT01961687?
The interventions under investigation include: Resorbable Mesh (DEVICE).
Who is sponsoring clinical trial NCT01961687?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01961687 being conducted?
This trial has 16 study locations across California, Florida, Illinois, Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01961687's enrollment target sits among peer trials
121 9th of 18 higher than 10 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia